selected publications
- NXP-2-positive dermatomyositis presenting with pronounced unilateral lower extremity subcutaneous edema. 2025 GET IT
- 30-day readmission after total hip and knee arthroplasty in patients with systemic lupus erythematosus: A US nationwide study. Journal of orthopaedics. 2025 Academic Article GET IT
- The Pendulum Swings on Glucocorticoids in Rheumatoid Arthritis. Annals of internal medicine. 2023 Editorial Article GET IT
-
Lupus-associated endogenous retroviral LTR polymorphism and epigenetic imprinting promote HRES-1/RAB4 expression and mTOR activation.
JCI insight.
2020
Academic Article
GET IT
Times cited: 19 -
Eosinophilic Fasciitis Following Checkpoint Inhibitor Therapy: Four Cases and a Review of Literature.
The oncologist.
2019
Review
GET IT
Times cited: 53 -
CD8 T cells and mTOR: new concepts and targets for systemic lupus erythematosus.
Lancet (London, England).
2018
Comment
GET IT
Times cited: 12 -
Plasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8.
Science translational medicine.
2018
Academic Article
GET IT
Times cited: 190 -
Mitochondrial Dysfunction in the Liver and Antiphospholipid Antibody Production Precede Disease Onset and Respond to Rapamycin in Lupus-Prone Mice.
Arthritis & rheumatology (Hoboken, N.J.).
2016
Academic Article
GET IT
Times cited: 129 -
What Causes Lupus Flares?.
Current rheumatology reports.
2016
Review
GET IT
Times cited: 27 -
HRES-1/Rab4-mediated depletion of Drp1 impairs mitochondrial homeostasis and represents a target for treatment in SLE.
Annals of the rheumatic diseases.
2013
Academic Article
GET IT
Times cited: 166 -
The proto-oncogene c-myc regulates antibody secretion and Ig class switch recombination.
Journal of immunology (Baltimore, Md. : 1950).
2013
Academic Article
GET IT
Times cited: 14 -
One size does not fit all: on how Markov model order dictates performance of genomic sequence analyses.
Nucleic acids research.
2012
Academic Article
GET IT
Times cited: 25 -
The role of the proto-oncogene c-myc in B lymphocyte differentiation.
Critical reviews in immunology.
2012
Review
GET IT
Times cited: 5 -
B Lymphocyte commitment program is driven by the proto-oncogene c-Myc.
Journal of immunology (Baltimore, Md. : 1950).
2011
Academic Article
GET IT
Times cited: 32 -
Endogenous retroviral pathogenesis in lupus.
Current opinion in rheumatology.
2010
Review
GET IT
Times cited: 69 -
Central role of nitric oxide in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus.
Arthritis research & therapy.
2010
Review
GET IT
Times cited: 142 -
mTOR signaling: a central pathway to pathogenesis in systemic lupus erythematosus?.
Discovery medicine.
2010
Review
GET IT
Times cited: 113 -
T-cell and B-cell signaling biomarkers and treatment targets in lupus.
Current opinion in rheumatology.
2009
Review
GET IT
Times cited: 43 -
Prevention of hepatocarcinogenesis and increased susceptibility to acetaminophen-induced liver failure in transaldolase-deficient mice by N-acetylcysteine.
The Journal of clinical investigation.
2009
Academic Article
GET IT
Times cited: 90 -
Activation of mammalian target of rapamycin controls the loss of TCRzeta in lupus T cells through HRES-1/Rab4-regulated lysosomal degradation.
Journal of immunology (Baltimore, Md. : 1950).
2009
Academic Article
GET IT
Times cited: 241 -
Reduced calmodulin expression accelerates transient outward potassium current inactivation in diabetic rat heart.
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology.
2008
Academic Article
GET IT
Times cited: 12 -
Metabolic control of T cell activation and death in SLE.
Autoimmunity reviews.
2008
Review
GET IT
Times cited: 94 -
Molecular mimicry and immunomodulation by the HRES-1 endogenous retrovirus in SLE.
Autoimmunity.
2008
Review
GET IT
Times cited: 54 -
Structural basis for ether-a-go-go-related gene K+ channel subtype-dependent activation by niflumic acid.
Molecular pharmacology.
2008
Academic Article
GET IT
Times cited: 20 -
The A4396G polymorphism in interferon regulatory factor 1 is frequently expressed in breast cancer cell lines.
Cancer genetics and cytogenetics.
2007
Academic Article
GET IT
Times cited: 14 -
Nitric oxide, mitochondrial hyperpolarization, and T cell activation.
Free radical biology & medicine.
2007
Review
GET IT
Times cited: 61 -
Signaling abnormalities in systemic lupus erythematosus as potential drug targets.
Endocrine, metabolic & immune disorders drug targets.
2006
Review
GET IT
Times cited: 19 -
Rapamycin reduces disease activity and normalizes T cell activation-induced calcium fluxing in patients with systemic lupus erythematosus.
Arthritis and rheumatism.
2006
Academic Article
GET IT
Times cited: 295 -
Regulation of CD4 expression via recycling by HRES-1/RAB4 controls susceptibility to HIV infection.
The Journal of biological chemistry.
2006
Academic Article
GET IT
Times cited: 68 -
Block of HERG channels by berberine: mechanisms of voltage- and state-dependence probed with site-directed mutant channels.
Journal of cardiovascular pharmacology.
2006
Academic Article
GET IT
Times cited: 37 -
Molecular mapping of a site for Cd2+-induced modification of human ether-à-go-go-related gene (hERG) channel activation.
The Journal of physiology.
2005
Academic Article
GET IT
Times cited: 26 -
Interferon regulatory factor-1 (IRF-1) exhibits tumor suppressor activities in breast cancer associated with caspase activation and induction of apoptosis.
Carcinogenesis.
2005
Academic Article
GET IT
Times cited: 113 -
Physicochemical basis for binding and voltage-dependent block of hERG channels by structurally diverse drugs.
Novartis Foundation symposium.
2005
Review
GET IT
Times cited: 42 -
interferon regulatory factor-1 mediates the proapoptotic but not cell cycle arrest effects of the steroidal antiestrogen ICI 182,780 (faslodex, fulvestrant).
Cancer research.
2004
Academic Article
GET IT
Times cited: 61